Early high-flow oxygen plus nebulized asthma medicine
Part of Lungs & breathing clinical trials.
This study tests whether giving fast, high-flow oxygen early—together with inhaled terbutaline via a vibrating mist—helps adults with moderate to severe asthma flare-ups in the emergency department. It aims to see if this approach improves breathing after initial treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be in the emergency department with suspected asthma flare-up
- After a first terbutaline (beta-2) nebulizer treatment, still have at least one sign of not improving (like fast breathing, low oxygen, low peak flow, or severe effort to breathe)
- Have not had an asthma flare-up in the past 30 days
- Be able to give informed consent yourself (no legal guardian/curator involved)
- Be able to receive beta-2 medicine (terbutaline) and the study’s oxygen treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving inhaled salbutamol (a medication that opens airways) through a nebulizer can help people with pneumonia who are having trouble breathing and need oxygen support. It looks at how the treatment affects lung function and breathing effort.
This study compares two different types of inhaled breathing treatments given in the emergency department for a sudden COPD flare-up. One treatment is long-acting (works longer) and the other is short-acting (works faster but wears off sooner). The goal is to see which one helps patients breathe better and recover faster.
This trial tests a device called MetaNeb that delivers high-frequency vibrations to help clear mucus and open collapsed air sacs in the lungs. It is designed for patients in the ICU who are awake, alert, and have trouble breathing or need extra oxygen.
This study looks at how asthma affects air flow and blood flow in your lungs. You may join if you use daily asthma control medicine and your breathing test shows room for improvement even after using a rescue inhaler.
This trial tests whether a special type of oxygen delivered through the nose (high-flow nasal oxygen) helps people hospitalized for a COPD flare-up. It is likely meant for people with significant breathing problems and recent repeat flare-ups.
This trial tests high-flow oxygen (a special oxygen delivery through a device) for people hospitalized with a bronchiectasis flare-up who need breathing support. It may help people avoid more invasive breathing machines and improve comfort and breathing during a severe episode.
Hear when a new Moderate Asthma Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.